CA
NZ
UK
AU
IND
US
Amgen Inc. (NASDAQ: AMGN) is one of the most-watched US large-cap biotech stocks as the company advances its MariTide obesity and metabolic diseaseFranchise. With a marketCapitalizationof about $176.11 billion, AMGN continues to anchor the diversified biotech sector. Shares fell 2.95%.
Abbott Laboratories (NYSE:ABT) is one of the most-watched US large-cap healthcare stocks. With a marketCapitalizationof about $147.13 billion, ABT continues to lead in diversified medical devices and diagnostics. Shares fell 0.51%.
Biogen (NASDAQ:BIIB) stock has slid as healthcare names lag behind the broader market rally, putting the spotlight on a sector that has struggled to keep pace with technology and other high-growth areas. The biotech company has been working through a complex period that includes …
Biogen (Nasdaq:BIIB) announced on Thursday that its Phase 2 CELIA study of diranersen did not meet its primary endpoint. Markets opened with optimism, with shares briefly surging in pre-market on the strength of the biomarker data, before the primary endpoint miss registered fully. As …
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) was a standout volume name on Top Gaining US Stocks screener for 13 May 2026. The screener recorded a single-session change of 25.77% to USD 4.93, with reported volume of 5.27 million shares — an extraordinary 39.27 times the stock's …
SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) was prominently featured on Top Gaining US Stocks screener for 13 May 2026. The screener recorded a single-session change of 25.10% to USD 6.53, with reported volume of 30.55 million shares — 7.61 times the stock's typical activity.
With a market capitalisation of approximately USD 437.63 million, REPL sits within the small-cap biotech segment — large enough for meaningful institutional involvement but small enough to experience significant single-sessionVolatilityon shifts in sentiment or perceived clinical risk.
With a market capitalisation of approximately USD 7.98 million, INBS is among the smaller names on the day's gainers list. That size, combined with a comparatively modest absolute share count, means that even relatively small dollar flows can produce significant percentage moves.
Electromed, Inc. (NYSE American: ELMD) was a notable name on Top Gaining US Stocks screener for 13 May 2026. The screener recorded a single-session change of 25.11% to USD 34.03, with reported volume of 227.53 thousand shares — 5.81 times the stock's typical activity.
Healthcare ETFs are down 7% in 2026 even as the S&P 500 gains. With UnitedHealth's collapse, managed care under pressure, and GLP-1 tailwinds intact, we examine whether XLV, VHT, and FHLC still offer a compelling entry point for long-term investors.Key HighlightsHealthcare sector valuations compressed …
Please wait processing your request...